SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.
about
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokinesRole of suppressors of cytokine signaling 3 in bone inflammatory responsesThe biology and mechanism of action of suppressor of cytokine signaling 3Immunoregulatory molecules are master regulators of inflammation during the immune responseMonocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface.Expression and functional significance of SOCS-1 and SOCS-3 in astrocytesPodocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk.Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes.SOCS3 regulates graft-versus-host disease.Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis.A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammationKaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasionIL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.Signal transduction pathways and transcriptional regulation in Th17 cell differentiationCD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study.Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways.Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.SOCS, Inflammation, and Autoimmunity.The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cellsGemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disordersRegulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins.Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development.Distinct regulation of interleukin-17 in human T helper lymphocytes.Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene ExpressionSTAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses.SOCS regulation of the JAK/STAT signalling pathway.Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.Effects of Controlled Cortical Impact on the Mouse Brain Vasculome.SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisCytokine signaling modules in inflammatory responses.Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.
P2860
Q24635387-868A8DD4-5C04-4816-85D0-BD3D8C55D420Q26853718-F23A5FFC-EC04-4DCE-B64D-105F39356B1FQ26994711-DCEEA923-C117-49E2-B2E4-DD824F7D9CA7Q27003933-3223D3C8-51D2-4AB0-9DA7-86E48F97E6DEQ27022027-BE169861-1BCF-4EF0-9FB7-45C3BB2A8F4BQ30842307-3941CC8B-40B7-4EB0-A09D-0CC237059E34Q33717808-1799722A-643C-46A1-A65E-6DA08B183957Q33795810-EC1DEC84-12B7-41EC-A40A-664F796C8A75Q33942523-B09CA527-12AF-418D-B5EC-E14663E8AA87Q34022451-8E104FA8-C13E-4F38-BFC7-0363873DB1DFQ34140190-5A6E83BE-3493-4CFA-9EA1-85DE8E973FA3Q34758768-1259D96C-075C-4252-9284-CF24B157E512Q34762453-CAA0F552-361C-48DE-9335-696ABD59D964Q35077642-C8C04555-23FD-428C-A25F-4FB298045CD3Q35137626-4DED0805-2A23-4BCE-9644-68ED436F78B9Q35238480-098E8EE4-F484-4987-94E9-08950AFA0078Q35360046-76A3EE35-F01E-45F6-9142-804240A243C0Q35366959-C0A77F5B-9DFB-4584-AC14-3155C2E287F2Q35459801-6B7CC46C-132C-4C1E-B3F7-43B9F72DB4BDQ35595320-3CA81B21-56D5-457F-8FFF-31E1C8B67167Q35812125-2393BA05-24C3-4E42-8959-F8536730C841Q35861951-C44F0E22-7EC4-4A7F-AC2C-50533F981B19Q35927538-0ECAAC08-9019-4C08-B72D-C8DE8AEF35CEQ35989418-A9840D68-1D0C-4219-B427-A6E42AB22002Q36061498-F6E2DD4D-D334-4CD6-B772-A990753DE4CDQ36137520-A43C14EC-FD1D-4410-A47A-426330609C39Q36141189-499C78A4-1D12-419F-A461-75CF01C67336Q36209324-1FAAAA2F-962C-4386-B372-557145B5C313Q36446884-F33BBD16-97D1-459E-994C-BA5DC4768667Q36532544-BAD5A87A-21D9-4B71-A055-EC6CD3DB77ABQ36571575-1F8E53EE-7048-4DF4-95D5-EC60B098675EQ36571580-F484C0D3-13C2-4372-9AA1-600A12752D68Q36727433-B12CEDE2-D242-43C5-BBD6-231B8A177BADQ36871967-80D96C30-1892-45E7-861B-1E837117C5F5Q37003892-C9FB530B-1F5E-451D-9D49-AD8118F9CE18Q37022886-8F768179-5674-4FC1-AA25-79E599827F4AQ37062141-DEB92D68-AAC6-4741-91E4-1CD5AB20FC2AQ37081582-F704A4BD-7B2C-4B8C-8BBD-F3A899E9E210Q37133450-ED446CB0-2098-4FC0-B452-084A6E4FD807Q37191397-3F7A9499-8818-41D9-94E7-BC36CC154120
P2860
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@ast
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@en
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@nl
type
label
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@ast
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@en
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@nl
prefLabel
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@ast
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@en
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@nl
P2093
P2860
P356
P1476
SOCS-3 negatively regulates in ...... endent inflammatory arthritis.
@en
P2093
Andrew W Roberts
Edward J McManus
Ian P Wicks
Kristy O'Donnell
Natalie A Sims
Paul J Egan
Peter K K Wong
Sarah Drake
Warren S Alexander
P2860
P304
P356
10.1172/JCI25660
P407
P50
P577
2006-05-18T00:00:00Z